We offer an extensive range of prescription products in various therapeutic categories. SanLiam offers a broad portfolio of both branded and generic drugs.
Driven by creativity and innovation, we strive for excellence and to make a difference in the world of pharmaceuticals and healthcare.
Kidney diseases, including chronic kidney disease (CKD), glomerulonephritis, and end-stage renal disease (ESRD), are increasingly prevalent worldwide, affecting millions of individuals every year. When kidney function is impaired, patients may face severe health complications. Despite advances in treatment, there is an urgent need for innovative therapies to slow disease progression, improve kidney function, and support patients in managing their condition effectively.
The Urocare Division is proud to offer a range of innovative therapies that help manage and treat urological conditions. Our treatment options aim to improve patient outcomes through targeted, effective therapies with fewer side effects and greater ease of use.
Our extensive portfolio includes a range of therapies designed to treat both common and complex gastrointestinal conditions. Our goal is to offer patients accessible and effective treatment options that provide relief and improve their quality of life.
Driven by a passion and curiosity, we address some of the most challenges by developing affordable solutions. We provide healthcare solutons to address the needs of patients and society.
Kidney diseases, like CKD and ESRD, are common, causing severe complications and requiring treatments to slow progression and improve outcomes.
The Urocare Division offers innovative therapies for urological conditions, improving outcomes with effective, user-friendly treatments.
Our portfolio offers therapies for gastrointestinal conditions, ensuring effective, accessible treatments to improve patients' quality of life.